Phosphodiesterase 10

Details Phosphodiesterase 10 Phosphodiesterase 10

2005-03-08

2005-03-08

Hutson, Richard (Department: 1652)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S196000, C435S069100, C530S350000, C424S094600, C536S023100, C536S023200

Reexamination Certificate

active

06864070

ABSTRACT:
The present invention provides novel human PDE10 polypeptides, polynucleotides encoding the polypeptides, expression constructs comprising the polynucleotides, host cells transformed with the expression constructs; methods for producing PDE10 polypeptides; antisense polynucleotides; and antibodies specifically immunoreactive with the PDE10 polypeptides. The invention further provides methods to identify binding partners of PDE 10, and more particularly, binding partners that modulate PDE10 enzyme activity.

REFERENCES:
patent: 5922595 (1999-07-01), Fisher et al.
patent: 0 044 527 (1981-07-01), None
patent: WO 9109955 (1991-07-01), None
patent: WO 9220808 (1992-11-01), None
patent: WO 9412650 (1994-06-01), None
patent: WO 9709433 (1997-03-01), None
Anderson, “Human gene therapy,”Nature,supplement to vol. 392, No. 6679, p. 25 (1998).
Ausbel, et al., “Screening of Recombinant DNA Libraries,”Current Protocols in Molecular Biology,John Wiley & Sons, pp. 6.0.3-6.4.10 (1994).
Avramopoulos, et al., “Linkage mapping of the cystathionine *-synthase (CBS) gene on human chromosome 21 using a DNA polymorphism in the 3′untranslated region,”Hum. Genet.90:566-568 (1993).
Beavo, “Cyclic Nucleotide Phosphodiesterases: Functional Implications of Multiple Isoforms,”Physiol. Rev.75:725-748 (1995).
Bolger, et al., “A Family of Human Phosphodiesterases Homologous to the dunce Learning and Memory Gene Product ofDrosophila melanogasterAre Potential Targets for Antidepressant Drugs,”Mol. Cell. Biol.13:6558-6571 (1993).
Bolger, et al., “Characterization of five different proteins produced by alternatively spliced MRNAs from the human cAMP-specific phosphodiesterase PD34D gene,”Biochem. J.328:539-548 (1997).
Bonne-Tamir, et al., “Linkage of Congenital Recessive Deafness (Gene DFNB10) to Chromosome 21q22.3,”Am. J. Hum. Genet.58:1254-1259 (1996).
Boolell, et al., “Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction,”Int. J. Impotence Res.8:47-50 (1996).
Bramlage, et al., “Designing ribozymes for the inhibition of gene expression,”Trends in Biotech16:434-438 (1998).
Cane, et al., “Harnessing the Biosynthetic Code: Combinations, Premutations, and Mutations,”Science282:63-68 (1998).
Capecchi, “Altering the Genome by Homologous Recombination,”Science244:1288-1292 (1989).
Charbonneau, et al., “Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species,”Proc. Natl. Acad. Sci.(USA) 83:9308-9312 (1986).
Collins, et al., “The Human *-Subunit of Rod Photoreceptor cGMP Phosphodiesterase: Complete Retinal cDNA Sequence and Evidence for Expression in Brain,”Genomics13:698-704 (1992).
Coste, et al., “Characterization of a Novel Potent and Specific Inhibitor of Type V Phosphodiesterase,”Biochem. Pharmacol.50:1577-1585 (1995).
Delabar, et al., “Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21,”Eur. J. Hum. Genet.1:114-124 (1993).
Francis, et al., “Zinc Interactions and Conserved Motifs of the cGMP-binding cGMP-specific Phosphodiesterase Suggest That It is a Zinc Hydrolase*,”J. Biol. Chem.269:22477-22480 (1994).
Friedmann, “Progress Toward Human Gene Therapy,”Science244:1275-1281 (1989).
Gibson, et al., “Ribozymes: Their Fucntions and Strategies for Their Use,”Mol. Biotech.7:125-137 (1997).
Harbinson, et al., “The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects,”Eur. Respir. J.10:1008-1014 (1997).
Harlow, et al., “Monoclonal Antibodies,”Antibodies: A Laboratory Manual,Cold Spring Harbor Laboratory; Cold Spring Harbor, NY Chapter 6 (1988).
Harlow, et al., “Fusion by Stirring (50% PEG)*,”Antibodies, a Laboratory Manual, Cold Spring Harbor Laboratory, p. 211 (1988).
Houston, et al., “The chemical-biological interface: developments in automated and miniaturlsed screening technology,”Curr. Opin. Biotechnol8:734-740 (1997).
Jayawickreme, et al., “Gene expression systems in the development of high-throughput screens,”Curr. Opin. Biotechnol.8:629-634 (1997).
Korenberg, et al., “Down syndrome phenotypes: The consequences of chromosomal imbalance,”Proc. Natl. Acad. Sci.(USA) 91:4997-5001 (1994).
Lavrovsky, et al., “Therapeutic Potential and Mechanism of Action of Oligonucleotides and Ribozymes,”Biochem. Mol. Med.62:11-22 (1997).
Lehninger, “The Amino Acid Building Blocks of Proteins,”Biochemistry,Second Edition; Worth Publishers, Inc. NY:NY pp. 71-77 (1975).
Loughney et al., “Isolation and Characterization of cDNAs Corresponding to Two Human Calcium, Calmodulin-regulated, 3′,5′-Cyclic Nucleotide Phosphodiesterases*,”J. Biol Chem.271:796-806 (1996).
Loughney, et al., “Identification and Quantification of PDE Isoenzymes and Subtypes by Molecular Biological Methods,”Phosphodiesterase Inhibitors,Academic Press: New York, New York pp. 1-19 (1996).
Manganiello et al., “Cyclic GMP-Inhibited cyclic Nucleotide Phosphodiesterases,”Isoenzymes of Cyclic Nucleotide Phosphodiesterases,John Wiley and Sons, Ltd., pp. 87-116 (1990).
Manganiello, et al., “Perspectives in Biochemistry and Biophysics Isoenzyme Families,”Arch. Biochem. Acta322:1-13 (1995).
Meacci, et al., “Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase,”Proc. Natl. Acad. Sci.(USA), 89:3721-3725 (1992).
Michaeli, et al., “Isolation and Characterization of a Previously Undetected Human cAMP Phosphodiesterase by Complementation of cAMP Phosphodiesterase-deficientSaccharomyces cerevisiae*,”J. Biol. Chem.17:12925-12932 (1993).
Miki, et al., “Characterization of the cDNA and Gene Encoding human PDE3B, the cGIP1 Isoform of the Human Cyclic GMP-Inhibited Cyclic Nucleotide Phosphodiesterase Family,”Genomics36:476-485 (1996).
Miller, “Human gene therapy comes of age,”Nature357:455-460 (1992).
Munke, et al., “The Gene for Cystathionine *-Synthase (CBS) Maps to the Subtelomeric Region on Human Chromosome 21q and to Proximal Mouse Chromosome 17,”Hum. Genet.42:550-559 (1988).
Myers, “Will combinational chemistry deliver real medicines?”Curr. Opion. Biotechnol.8:701-707 (1997).
Pittler, et al., “Molecular Characterization of Human and Bovine Rod Photoreceptor cGMP Phosphodiesterase *-Subunit and Chromosomal Localization of the Human Gene,”Genomics6:272-283 (1990).
Piriev, et al., “Gene Structure and Amino Acid Sequence of the Human Cone photoreceptor cGMP-Phosphodiesterase *' Subunit (PDEA2) and Its Chromosomal Localization to 10q24,”Genomics28:429-435 (1995).
Podzuweit, et al., “Isozyme Selective Inhibition of cGMP-Stimulated Cyclic Nucleotide Phosphodiesterases by Erythro-9-(2-Hydroxy-3-Nonly) Adenine,”Cell. Signaling7:733-738 (1995).
Price, et al., “Expression of Heterologous Proteins inSaccharomyces cerevisiaeUsing the ADH2 Promoter,”Meth. Enzymol.185:308-315 (1990).
Rosman, et al., “Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase1,”Gene191:89-95 (1997).
Sambrook, et al., “Hybridization of Radiolabeled Probes to Immobilized Nucleic Acids,”Molecular Cloning: A Laboratory Manual,Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York (1989), pp. 9.47-9.51.
Schudt, et al., “Analysis of PDE4 Isoenzyme Profiles in Cells and Tissues by Pharmacological Methods,”Phosphodiesterase Inhibitors,Academic Press: New York, New York pp. 21-40 (1996).
Sertie, et al., “A gene which causes severe ocular alterations and occipital enceph

Affiliated with

Also associated with

Rating

Phosphodiesterase 10 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphodiesterase 10, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesterase 10 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3440883